|1.||Kim, Young: 2 articles (07/2013 - 05/2012)|
|2.||Schmidt-Wolf, Ingo G H: 2 articles (07/2013 - 05/2012)|
|3.||Meschenmoser, Karoline: 2 articles (07/2013 - 05/2012)|
|4.||Stupp, Samuel I: 2 articles (01/2013 - 04/2010)|
|5.||Iglesias, Raul: 1 article (12/2015)|
|6.||Koria, Piyush: 1 article (12/2015)|
|7.||Lin, Heng: 1 article (02/2014)|
|8.||Hu, Zhuo-Wei: 1 article (02/2014)|
|9.||Lv, Xiao-Xi: 1 article (02/2014)|
|10.||Sun, Wei: 1 article (02/2014)|
07/01/2013 - "We designed a novel cancer-specific killer peptide created by fusion of the toxic peptide (KLAKLAK)2 with the cancer recognition peptide LTVSPWY. "
05/01/2012 - "Our data suggest a potential use of (KLAKLAK)(2) peptide for patients with breast and other types of cancer."
08/01/2011 - "In a mouse model, the RAFT-RGD-KLA peptide was found to prevent the growth of remote subcutaneous tumors. "
08/01/2011 - "At 2.5 µM, this molecule induced the intracellular release of an active KLA peptide, which in turn caused mitochondrial depolarization and cell death in vitro in tumor cells. "
04/15/2010 - "Significantly, (KLAKLAK)(2) nanostructures induced cell death more robustly in transformed breast epithelial cells than in untransformed cells, suggesting a degree of tumor selectivity. "
|2.||BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/01/2014 - "Moreover, a synthetic, chimeric peptide composed of the TLR2-binding motif linked to a programmed cell death-inducing sequence, D(KLAKLAK)2, induced apoptosis in AML cells with high TLR2 expression (TLR2(high)) but not in chronic myeloid leukemia (CML) cells with low TLR2 expression (TLR2(low)). "
01/01/2013 - "Our group has previously designed and developed a proteolytically-resistant peptidomimetic motif D(KLAKLAK)2 with pleiotropic action ranging from targeted (i.e., ligand-directed) activity against cancer and obesity to non-targeted activity against antibiotic resistant gram-negative rods. "
|5.||Lung Neoplasms (Lung Cancer)
|1.||Caspase 3 (Caspase-3)
|2.||Fibroblast Growth Factor 7
|5.||Staphylococcal Protein A (A, Protein)
|7.||Hyaluronic Acid (Hyaluronan)
|1.||Heterologous Transplantation (Xenotransplantation)